Global Radiation Dose Management Market: Analysis and Forecast, 2021-2030

Table of Contents

Executive Summary 1 Market Overview 1.1 Introduction 1.1.1 Natural Radiation Sources 1.1.2 Biological Effects of Radiation 1.1.3 Usage of Radiation in Medical Devices 1.1.4 Radiation Dose 1.1.5 Effective Radiation Dose 1.1.6 Factors Contributing to Unnecessary Radiation Exposure 2 Product Definition 3 Scope of Research Study 3.1 Scope of the Study 3.2 Exclusion Criteria of the Report 3.3 Key Questions Answered in the Report 3.4 Forecast Period Selection Criteria 4 Research Scope and Methodology 4.1 Research Methodology 4.2 Primary Data Sources 4.3 Secondary Data Sources 4.4 Data and Prediction Modeling 4.5 Selection Criteria for Company Profiles 4.6 Brief Overview of Market Estimation Process 4.7 Data Validation 4.8 Assumptions and Limitations 5 COVID-19 Impact Analysis 5.1 Impact on Radiation Diagnostic Industry 5.1.1 Industry Analysis 5.1.2 Long-, Mid-, and Short-Term Impact 5.1.3 Impact on Radiation Diagnostic Equipment (CT Scanners, X-Ray, Mammography System, PET Scanners and SPECT, and Others) 5.2 Trend Analysis for Radiation Dose Management Market 5.2.1 Pre-COVID-19 5.2.2 Post-COVID-19 5.3 Regional Impact of COVID-19 Industry 5.3.1 North America 5.3.2 Europe 5.3.3 Asia-Pacific 5.3.4 Rest-of-the-World 5.4 Change in Competitive Landscape and Product Demand 5.5 Emerging Opportunities due to COVID-19 in Radiation Dose Management 5.6 Future Prospective: Post COVID-19 Scenarios and Recommendations 6 Global Radiation Dose Management Market Scenario 6.1 Historical Trends 6.2 Trends for Radiation Dose Management 6.3 Global Radiation Dose Management Scenario 6.4 Assumptions and Limitations 6.5 Key Findings and Opportunity Assessment 6.5.1 Key Findings 6.5.2 Opportunity Assessment 6.6 Market Dynamics 6.6.1 Overview 6.6.2 Impact Analysis 6.6.3 Market Drivers 6.6.3.1 Increasing Installed Bases of Radiology Equipment and Number of Scans 6.6.3.2 Growing Geriatric Population 6.6.3.3 Increasing Prevalence of Chronic and Lifestyle-Associated Diseases 6.6.3.3.1 Increasing Prevalence of Cancer 6.6.3.3.2 Increasing Prevalence of Cardiovascular Diseases 6.6.3.3.3 Increasing Prevalence of Respiratory Diseases 6.6.3.4 Increasing Regulatory Requirements for Diagnostic Devices 6.6.3.5 Increasing Concern Related to Radiation Over Exposure 6.6.3.6 Growing Awareness and Initiatives for Radiation Dose Management 6.6.4 Market Restraints 6.6.4.1 Lack of Skilled and Trained Professionals 6.6.4.2 High Cost Associated with Radiation Dose Software 6.6.5 Opportunities 6.6.5.1 Innovation 6.6.5.1.1 Technological Advancements in Medical Imaging 6.6.5.1.2 Impact of Cloud-Based Solutions 6.6.5.2 Regulatory Focus on Pediatric Procedures 6.6.5.2.1 Radiation Dose Management for Pediatric Procedures 6.6.5.3 Regional Expansion and Increasing Adoption of Radiation Dose Management Software in Emerging Economies 7 Competitive Landscape 7.1 Key Developments and Strategies 7.1.1 Collaborations, Agreements, and Partnerships 7.1.2 Product Launches 7.1.3 Regulatory Approvals 7.1.4 Mergers and Acquisitions 7.2 Market Share Analysis 7.2.1 Market Share Analysis, by Company 8 Radiation Dose Management Pricing Analysis 8.1 Manual Dose Data Recording Cost Per Examination 8.2 Radiation Dose Management Software Pricing 8.3 Server Fee 9 Industry Insights 9.1 Patent Analysis 9.1.1 Patent Analysis (by Modality Type) 9.2 Regulatory Requirements 9.3 Bills and Acts for Radiation Dose Management 9.4 Alliances 9.5 Associations and Consortiums 10 Global Radiation Dose Management Market (by Modality) 10.1 CT Scanners 10.2 X-Ray, CR, and DR 10.3 Mammography System 10.4 Interventional Angiography Systems/Angio CT 10.5 Fluoroscopy Systems 10.6 PET Scanners and SPECT 10.7 Hybrid Imaging 11 Global Radiation Dose Management Market (by Product) 11.1 Introduction 11.2 Radimetrics Enterprise Platform 11.2.1 Key Features 11.2.2 Radimetrics Enterprise Platform- Global Market 11.2.3 Installed Base and Number of Customers 11.2.4 Compatible Modalities 11.2.5 Competitive Benchmarking 11.3 DoseWatch and Dose Watch Explorer 11.3.1 Key Features 11.3.2 DoseWatch and DoseWatch Explorer- Global Market 11.3.3 Installed Base and Number of Customers 11.3.4 Compatible Modalities 11.3.5 Competitive Benchmarking 11.4 teamplay Dose 11.4.1 Key Features 11.4.2 teamplay Dose- Global Market 11.4.3 Installed Base and Number of Customers 11.4.4 Compatible Modalities 11.4.5 Competitive Benchmarking 11.5 NEXO [DOSE] 11.5.1 Key Features 11.5.2 NEXO [DOSE]- Global Market 11.5.3 Installed Base and Number of Customers 11.5.4 Compatible Modalities 11.5.5 Competitive Benchmarking 11.6 tqm/Dose and DoseMonitor 11.6.1 Key Features 11.6.2 tqm/Dose and DoseMonitor- Global Market 11.6.3 Installed Base and Number of Customers 11.6.4 Compatible Modalities 11.6.5 Competitive Benchmarking 11.7 Radiation Dose Monitor 11.7.1 Key Features 11.7.2 Radiation Dose Monitor- Global Market 11.7.3 Installed Base and Number of Customers 11.7.4 Compatible Modalities 11.7.5 Competitive Benchmarking 11.8 Imalogix Platform 11.8.1 Key Features 11.8.2 Imalogix Platform- Global Market 11.8.3 Installed Base and Number of Customers 11.8.4 Compatible Modalities 11.8.5 Competitive Benchmarking 11.9 Syncro-Dose and Aspire AWS 11.9.1 Key Features 11.9.2 Syncro-Dose- Global Market 11.9.3 Installed Base and Number of Customers 11.9.4 Compatible Modalities 11.9.5 Competitive Benchmarking 11.1 NovaDose 11.10.1 Key Features 11.10.2 NovaDose- Global Market 11.10.3 Installed Base and Number of Customers 11.10.4 Compatible Modalities 11.10.5 Competitive Benchmarking 11.11 DoseWise Portal 11.11.1 Key Features 11.11.2 DoseWise Portal- Global Market 11.11.3 Installed Base and Number of Customers 11.11.4 Compatible Modalities 11.11.5 Competitive Benchmarking 11.12 SafeCT 11.12.1 Key Features 11.12.2 SafeCT- Global Market 11.12.3 Installed Base and Number of Customers 11.12.4 Compatible Modalities 11.12.5 Competitive Benchmarking 11.13 MyXrayDose 11.13.1 Key Features 11.13.2 MyXrayDose- Global Market 11.13.3 Installed Base and Number of Customers 11.13.4 Compatible Modalities 11.13.5 Competitive Benchmarking 11.14 DoseM 11.14.1 Key Features 11.14.2 DoseM- Global Market 11.14.3 Installed Base and Number of Customers 11.14.4 Compatible Modalities 11.14.5 Competitive Benchmarking 11.15 Dose Tracking System 11.15.1 Key Features 11.15.2 Dose Tracking System- Global Market 11.15.3 Installed Base and Number of Customers 11.15.4 Compatible Modalities 11.15.5 Competitive Benchmarking 11.16 DoseTrack 11.16.1 Key Features 11.16.2 DoseTrack- Global Market 11.16.3 Installed Base and Number of Customers 11.16.4 Compatible Modalities 11.16.5 Competitive Benchmarking 12 Global Radiation Dose Management Market (by Mode of Deployment) 12.1 Introduction 12.2 Competitive Benchmarking 12.3 Web-Based 12.4 On-Premises 12.5 Cloud-Based 13 Global Radiation Dose Management Market (by End Users) 13.1 Introduction 13.2 Hospital 13.3 Diagnostic Centers 13.4 Others 14 Global Radiation Dose Management Market (by Region) 14.1 North America Radiation Dose Management Market 14.1.1 North America: Radiation Dose Management Market (by Modality) 14.1.2 North America: Radiation Dose Management (by End User) 14.1.3 North America Radiation Dose Management Market (by Country) 14.1.3.1 U.S. 14.1.3.1.1 U.S. Radiation Dose Management (by End User) 14.1.3.2 Canada 14.1.3.2.1 Canada Radiation Dose Management (by End User) 14.1.4 Regulation 14.1.5 Developments 14.2 Europe 14.2.1 Europe Radiation Dose Management Market (by Modality) 14.2.2 Europe Radiation Dose Management (by End User) 14.2.3 Europe Radiation Dose Management Market (by Country) 14.2.3.1 Germany 14.2.3.1.1 Germany Radiation Dose Management (by End User) 14.2.3.2 France 14.2.3.2.1 France Radiation Dose Management (by End User) 14.2.3.3 Italy 14.2.3.3.1 Italy Radiation Dose Management (by End User) 14.2.3.4 U.K. 14.2.3.4.1 U.K. Radiation Dose Management (by End User) 14.2.3.5 Spain 14.2.3.5.1 Spain Radiation Dose Management (by End User) 14.2.3.6 Netherlands 14.2.3.6.1 Netherlands Radiation Dose Management (by End User) 14.2.3.7 Russia 14.2.3.7.1 Russia Radiation Dose Management (by End User) 14.2.3.8 Rest-of-Europe 14.2.3.9 Rest-of-Europe Radiation Dose Management (by End User) 14.2.4 Regulation 14.2.5 Developments 14.3 Asia-Pacific Radiation Dose Management Market 14.3.1 Asia-Pacific Radiation Dose Management Market (by Modality) 14.3.2 Asia-Pacific Radiation Dose Management (by End User) 14.3.3 Asia-Pacific Radiation Dose Management Market (by Country) 14.3.3.1 Japan 14.3.3.1.1 Japan Radiation Dose Management (by End User) 14.3.3.2 China 14.3.3.2.1 China Radiation Dose Management (by End User) 14.3.3.3 Australia and New Zealand 14.3.3.3.1 Australia and New Zealand Radiation Dose Management (by End User) 14.3.3.4 South Korea 14.3.3.4.1 South Korea Radiation Dose Management (by End User) 14.3.3.5 India 14.3.3.5.1 India Radiation Dose Management (by End User) 14.3.3.6 Rest-of-Asia-Pacific 14.3.3.6.1 Rest of Asia-Pacific Radiation Dose Management (by End User) 14.3.4 Regulations 14.3.5 Developments 14.4 Latin America 14.4.1 Latin America Radiation Dose Management Market (by Modality) 14.4.2 Latin America Radiation Dose Management (by End User) 14.4.3 Latin America Radiation Dose Management Market (by Country) 14.4.3.1 Brazil 14.4.3.2 Brazil Radiation Dose Management (by End User) 14.4.3.3 Mexico 14.4.3.3.1 Mexico Radiation Dose Management (by End User) 14.4.3.4 Rest-of-Latin America 14.4.3.4.1 Rest-of-Latin America Radiation Dose Management (by End User) 14.4.4 Regulations 14.5 Rest-of-the-World 14.5.1 Rest-of-the-World Radiation Dose Management Market (by Modality) 14.5.2 Rest-of-the-World Radiation Dose Management (by End User) 14.5.3 Rest-of-the-World Radiation Dose Management Market (by Country) 14.5.3.1 Middle East 14.5.3.1.1 Middle East Radiation Dose Management (by End User) 14.5.3.2 Africa 14.5.3.2.1 Africa Radiation Dose Management (by End User) 14.5.4 Regulations 15 Company Profiles 15.1 Agfa-Gevaert Group 15.1.1 Company Overview 15.1.2 Role of Agfa Gevaert Group in the Radiation Dose Management Market 15.1.3 Financials 15.1.4 Recent Development 15.1.5 SWOT Analysis 15.2 Bayer AG 15.2.1 Company Overview 15.2.2 Role of Bayer AG in the Radiation Dose Management Market 15.2.3 Financials 15.2.4 Recent Development 15.2.5 SWOT Analysis 15.3 Bracco 15.3.1 Company Overview 15.3.2 Role of Bracco in the Radiation Dose Management Market 15.3.3 Recent Development 15.3.4 SWOT Analysis 15.4 Canon Inc. 15.4.1 Company Overview 15.4.2 Role of Canon Inc. in the Radiation Dose Management Market 15.4.3 Financials 15.4.4 Recent Development 15.4.5 SWOT Analysis 15.5 Fujifilm Holdings Corporation 15.5.1 Company Overview 15.5.2 Role of Fujifilm Holdings Corporation in the Radiation Dose Management Market 15.5.3 Financials 15.5.4 SWOT Analysis 15.6 Guerbet Group 15.6.1 Company Overview 15.6.2 Role of Guerbet LLC in the Radiation Dose Management Market 15.6.3 Financials 15.6.4 Recent Development 15.6.5 SWOT Analysis 15.7 General Electric Company 15.7.1 Company Overview 15.7.2 Role of General Electric Company in Radiation Dose Management Market 15.7.3 Financials 15.7.4 Recent Development 15.7.5 SWOT Analysis 15.8 Imalogix 15.8.1 Company Overview 15.8.2 Role of Imalogix in the Radiation Dose Management Market 15.8.3 Recent Development 15.8.4 SWOT Analysis 15.9 Infinitt Healthcare Co., Ltd. 15.9.1 Company Overview 15.9.2 Role of Infinitt Healthcare Co., Ltd. in the Radiation Dose Management Market 15.9.3 Recent Development 15.9.4 SWOT Analysis 15.1 Koninklijke Philips N.V. 15.10.1 Company Overview 15.10.2 Role of Koninklijke Philips N.V. in the Radiation Dose Management Market 15.10.3 Financials 15.10.4 Recent Development 15.10.5 SWOT Analysis 15.11 Medic Vision Imaging Solutions Ltd. 15.11.1 Company Overview 15.11.2 Role of Medic Vision Imaging Solutions Ltd. in the Radiation Dose Management Market 15.11.3 Recent Development 15.11.4 SWOT Analysis 15.12 Medsquare 15.12.1 Company Overview 15.12.2 Role of Medsquare in the Radiation Dose Management Market 15.12.3 Recent Development 15.12.4 SWOT Analysis 15.13 MyXrayDose Ltd. 15.13.1 Company Overview 15.13.2 Role of MyXrayDose Ltd. in the Radiation Dose Management Market 15.13.3 SWOT Analysis 15.14 Novarad Corporation 15.14.1 Company Overview 15.14.2 Role of Novarad Corporation in the Radiation Dose Management Market 15.14.3 Recent Development 15.14.4 SWOT Analysis 15.15 PACSHealth, LLC 15.15.1 Company Overview 15.15.2 Role of PACSHealth LLC in the Radiation Dose Management Market 15.15.3 Recent Development 15.15.4 SWOT Analysis 15.16 Qaelum NV 15.16.1 Company Overview 15.16.2 Role of Qaelum NV in the Radiation Dose Management Market 15.16.3 Recent Development 15.16.4 SWOT Analysis 15.17 Sectra AB 15.17.1 Company Overview 15.17.2 Role of Sectra AB in the Radiation Dose Management Market 15.17.3 Financials 15.17.4 Recent Development 15.17.5 SWOT Analysis 15.18 SST Group Inc. 15.18.1 Company Overview 15.18.2 Role of SST Group Inc. in the Radiation Dose Management Market 15.18.3 Recent Development 15.18.4 SWOT Analysis 15.19 Siemens Healthineers, Inc. 15.19.1 Company Overview 15.19.2 Role of Siemens Healthineers, Inc. in the Radiation Dose Management Market 15.19.3 Financials 15.19.4 Recent Development 15.19.5 SWOT Analysis 15.2 Virtual Phantom, Inc. 15.20.1 Company Overview 15.20.2 Role of Virtual Phantom, Inc. in the Radiation Dose Management Market 15.20.3 Key Developments 15.20.4 SWOT Analysis List of Tables Table 1: Impact Analysis of Market Drivers and Restraints Table 2: Company Distribution Based on Mode of Deployment Table 1.1: Effective Radiation Dose for Adults for Radiology Procedures Table 5.1: Vaccines Approved for COVID-19 Table 5.2: Imaging Procedures in 2020 and 2019 by Patient Service Locations, New York Table 5.3: Imaging Procedures in 2020 and 2019 by Imaging Modality Types, New York Table 5.4: COVID-19 Vaccines Granted for Emergency Use in North America Table 5.5: Healthcare Expenditure During FY2020 Across Various Regions in Europe Table 5.6: COVID-19 Vaccines Granted for Emergency Use in Europe Table 5.7: COVID-19 Vaccines Granted for Emergency Use in Asia-Pacific Table 5.8: COVID-19 Vaccines Granted for Emergency Use in Rest-of-the-World Table 6.1: Impact Analysis of Market Drivers and Restraints Table 9.1: Global Radiation Dose Management System Patent Technology and Their Application Table 9.2: List of Major Regulatory Bodies Table 9.3: Some of the Bills and Acts for Radiation Dose Management Table 9.4: Some of the Alliances for Radiation Dose Management Table 9.5: Associations/Consortiums of the Global Radiation Dose Management Market Table 10.1: Effective Radiation Dose from Diagnostic CT Procedure Table 10.2: Effective Price Range of CT Scan in Different States in the U.S. for CT Scans Table 10.3: Effective Radiation Dose from Diagnostic X-Ray-Single Exposure Table 11.1: Competitive Benchmarking Table 11.2: Competitive Benchmarking Table 11.3: Competitive Benchmarking Table 11.4: Competitive Benchmarking Table 11.5: Competitive Benchmarking Table 11.6: Competitive Benchmarking Table 11.7: Competitive Benchmarking Table 11.8: Competitive Benchmarking Table 11.9: Competitive Benchmarking Table 11.10: Competitive Benchmarking Table 11.11: Competitive Benchmarking Table 11.12: Competitive Benchmarking Table 11.13: Competitive Benchmarking Table 11.14: Competitive Benchmarking Table 11.15: Competitive Benchmarking Table 12.1: Competitive Benchmarking on the basis of Mode of Deployment Table 14.1: Number of Cases of Cancer Latin America, 2020 Table 14.2: Number of Cases of Cancer in Brazil, 2020 Table 14.3: Number of Cases of Cancer in Mexico, 2020 List of Figures Figure 1: Global Radiation Dose Management Market Value, 2019-2030 Figure 2: Radiation Dose Management Market, Pre-COVID-19 and Post-COVID-19 Scenario, $Million Figure 3: Dominating Segments of Global Radiation Dose Management Market, 2020 and 2030 Figure 4: Global Radiation Dose Management Market (by Modality), Share Analysis, 2020-2030 Figure 5: Global Radiation Dose Management Market (by Mode of Deployment), Share Analysis, 2020 and 2030 Figure 6: Global Radiation Dose Management Market (by End Users), Share Analysis, 2020 and 2030 Figure 7: Global Radiation Dose Management Market (by Region), 2020 Figure 8: Key Strategies Incorporated by the Key Players in the Radiation Dose Management Market (January 2012–November 2020) Figure 9: Market Share Analysis for the Global Radiation Dose Management Market (by Company), 2019 Figure 1.1: Sources of Radiation Exposure in the U.S. Figure 1.2: Dose From Natural Background Radiation (mSv) Figure 1.3: Different Types of Radiation Doses Figure 3.1: Global Radiation Dose Management: Market Segmentation Figure 4.1: Radiation Dose Management Market Research Methodology Figure 4.2: Primary Research Figure 4.3: Secondary Research Figure 4.4: Considered Factors for Data Prediction and Modeling Figure 4.5: Total Number of Companies Profiled Figure 4.6: Assumptions and Limitations Figure 5.1: Long-, Mid-, and Short-Term Impact of COVID-19 on Radiation Dose Management Market Figure 5.2: Number of Scans by Imaging Modalities in the U.K. from January 2020– May 2020 Figure 5.3: Radiation Dose Management Market, Pre-COVID-19 and Post-COVID-19 Scenarios, $Million Figure 5.4: Product Demand for Radiation Dose Management Software Figure 5.5: Various Technological Opportunity Came During COVID-19 Figure 5.6: Recommendations for Hospitals to Optimize the Radiation Dose Process Figure 6.1: Historic Evolution of X-Rays Figure 6.2: Historical Evolution of Radiation Dose Management Software Figure 6.3: Global Radiation Dose Management Market, 2019-2030 Figure 6.4: Market Dynamics Figure 6.5: Number of Scans by Imaging Modalities in the U.K. From 2015-16 to 2019-20 Figure 6.6: Geriatric Population (60 Years and Above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050 Figure 6.7: Number of Incidence Cases of Cancer in 2018 and 2040 Figure 6.8: Regulatory Bodies for Radiology Diagnostic Devices Figure 6.9: Major Concerns Related to Overexposure of Radiation in Medical Imaging Devices and Procedures Figure 7.1: Share of Key Developments and Strategies, January 2012–November 2020 Figure 7.2: Collaborations, Agreements, and Partnerships (by Company), January 2012–November 2020 Figure 7.3: Product Launches and Approvals (by Company), January 2012– November 2020 Figure 7.4: Regulatory Approvals (by Company), January 2012–November 2020 Figure 7.5: Mergers and Acquisitions (by Company), January 2012–November 2020 Figure 7.6: Market Share Analysis for the Global Radiation Dose Management Market (by Company), 2019 Figure 9.1: Patent Segmentation, by Year Figure 9.2: Patent Segmentation, by Country Figure 9.3: Patent Segmentation, by Modality Figure 9.4: Patent Segmentation, by Modality Type Figure 10.1: Segmentation of Radiation Dose Management Market, by Modality Figure 10.2: Global Radiation Dose Management Market (by Modality), Market Share, 2020 Figure 10.3: Global Radiation Dose Management Market (by Modality), 2019-2030 Figure 10.4: Benefits of the CT scan Figure 10.5: CT Scanner in the Global Radiation Dose Management Market, 2019-2030 Figure 10.6: CT Scanners Radiation Dose Management Market (by Region), 2019-2030 Figure 10.7: X-Ray, CR, and DR in the Global Radiation Dose Management Market, 2019-2030 Figure 10.8: X-Ray, CR, and DR Radiation Dose Management Market (by Region), 2019-2030 Figure 10.9: Mammography Systems in the Global Radiation Dose Management Market, 2019-2030 Figure 10.10: Mammography Systems Radiation Dose Management Market (by Region), 2019-2030 Figure 10.11: Interventional Angiography Systems/Angio CT in the Global Radiation Dose Management Market, 2019-2030 Figure 10.12: Interventional Angiography Systems/Angio CT Radiation Dose Management Market (by Region), 2019-2030 Figure 10.13: Benefits of Fluoroscopy System Figure 10.14: Fluoroscopy Systems in the Global Radiation Dose Management Market, 2019-2030 Figure 10.15: Fluoroscopy Systems Radiation Dose Management Market (by Region), 2019-2030 Figure 10.16: PET Scanners and SPECT in the Global Radiation Dose Management Market, 2019-2030 Figure 10.17: PET Scanners and SPECT Radiation Dose Management Market (by Region), 2019-2030 Figure 10.18: Hybrid Imaging in the Global Radiation Dose Management Market, 2019-2030 Figure 10.19: Hybrid Imaging Radiation Dose Management Market (by Region), 2019-2030 Figure 11.1: Segmentation of Radiation Dose Management Market, (by Product Type) Figure 11.2: Global Radiation Dose Management Market (by Product Type), 2020 and 2030 Figure 11.3: Global Radiation Dose Management Market (Radimetrics Enterprise Platform), 2019-2030 Figure 11.4: Installed Base and Number of Customers, 2018 and 2019 Figure 11.5: Compatible Modalities of Radimetrics Enterprise Platform Figure 11.6: Global Radiation Dose Management Market (DoseWatch), 2019-2030 Figure 11.7: Installed Base and Number of Customers, 2018 and 2019 Figure 11.8: Compatible Modalities of DoseWatch Figure 11.9: Global Radiation Dose Management Market (teamplay Dose), 2019-2030 Figure 11.10: Installed Base and Number of Customers, 2018 and 2019 Figure 11.11: Compatible Modalities of teamplay Dose Figure 11.12: Global Radiation Dose Management Market (NEXO [DOSE]), 2019-2030 Figure 11.13: Installed Base and Number of Customers, 2018 and 2019 Figure 11.14: Compatible Modalities of NEXO [DOSE] Figure 11.15: Global Radiation Dose Management Market ( tqm/Dose and DoseMonitor), 2019-2030 Figure 11.16: Installed Base and Number of Customers, 2019 and 2020 Figure 11.17: Compatible Modalities of tqm/Dose and DoseMonitor Figure 11.18: Global Radiation Dose Management Market (Radiation Dose Monitor), 2019-2030 Figure 11.19: Installed Base and Number of Customers, 2018 and 2019 Figure 11.20: Compatible Modalities of Radiation Dose Monitor Figure 11.21: Global Radiation Dose Management Market (Imalogix Platform), 2019-2030 Figure 11.22: Installed Base and Number of Customers, 2018 and 2019 Figure 11.23: Compatible Modalities of Imalogix Platform Figure 11.24: Global Radiation Dose Management Market (Syncro-Dose), 2019-2030 Figure 11.25: Installed Base and Number of Customers, 2018 and 2019 Figure 11.26: Compatible Modalities of Syncro-Dose Figure 11.27: Global Radiation Dose Management Market (NovaDose), 2019-2030 Figure 11.28: Installed Base and Number of Customers, 2018 and 2019 Figure 11.29: Compatible Modalities of NovaDose Figure 11.30: Global Radiation Dose Management Market (DoseWise Portal), 2019-2030 Figure 11.31: Installed Base and Number of Customers, 2018 and 2019 Figure 11.32: Compatible Modalities of DoseWise Portal Figure 11.33: Global Radiation Dose Management Market (SafeCT), 2019-2030 Figure 11.34: Installed Base and Number of Customers, 2018 and 2019 Figure 11.35: Compatible Modalities of SafeCT Figure 11.36: Global Radiation Dose Management Market (MyXrayDose), 2019-203 Figure 11.37: Installed Base and Number of Customers, 2018 and 2019 Figure 11.38: Compatible Modalities of MyXrayDose Figure 11.39: Global Radiation Dose Management Market (DoseM), 2019-2030 Figure 11.40: Installed Base and Number of Customers, 2018 and 2019 Figure 11.41: Compatible Modalities of DoseM Figure 11.42: Global Radiation Dose Management Market (Dose Tracking System), 2019-2030 Figure 11.43: Installed Base and Number of Customers, 2018 and 2019 Figure 11.44: Compatible Modalities of the Dose Tracking System Figure 11.45: Global Radiation Dose Management Market (DoseTrack), 2019-2030 Figure 11.46: Installed Base and Number of Customers, 2018 and 2019 Figure 11.47: Compatible Modalities of DoseTrack Figure 12.1: Segmentation of Radiation Dose Management Market (by Mode of Deployment) Figure 12.2: Global Radiation Dose Management Market (by Mode of Deployment), 2019-2030 Figure 12.3: Global Radiation Dose Management Installed Base (by Mode of Deployment), 2019-2030 Figure 12.4: Global Radiation Dose Management Market (Web-Based), 2019-2030 Figure 12.5: Web-Based Radiation Dose Management Market (by Region), 2019-2030 Figure 12.6: Global Radiation Dose Management Market (On-Premises), 2019-2030 Figure 12.7: On-Premises Radiation Dose Management Market (by Region), 2019-2030 Figure 12.8: Global Radiation Dose Management Market (Cloud-Based), 2019-2030 Figure 12.9: Cloud-Based Radiation Dose Management Market (by Region), 2019-2030 Figure 13.1: Segmentation of Radiation Dose Management Market (by End User) Figure 13.2: Global Radiation Dose Management Market (by End User), 2020 and 2030 Figure 13.3: Global Radiation Dose Management Market (Hospital), 2019-2030 Figure 13.4: Global Radiation Dose Management Market (Diagnostic Centers), 2019-2030 Figure 13.5: Global Radiation Dose Management Market (by Others), 2019-2030 Figure 14.1: Global Radiation Dose Management Market (by Region), 2020 Figure 14.2: Global Radiation Dose Management Market (by Region), $Million, 2019-2030 Figure 14.3: North America Radiation Dose Management Market, $Million, 2019-2030 Figure 14.4: North America: Market Dynamics Figure 14.5: North America: Radiation Dose Management Market (by Modality), 2019-2030 Figure 14.6: North America: Radiation Dose Management Market (by End User), 2019-2030 Figure 14.7: North America: Radiation Dose Management Market (by Country), 2020 and 2030 Figure 14.8: Patient Data of New Cancer Cases by Cancer Type in the U.S.(2020) Figure 14.9: U.S. Radiation Dose Management Market, 2019-2030 Figure 14.10: U.S. Radiation Dose Management Market (by End User), 2019-2030 Figure 14.11: Number of Units of Imaging Devices in Canada in 2017 Figure 14.12: Key Features of Imaging Devices in Canada Figure 14.13: Canada Radiation Dose Management Market, 2019-2030 Figure 14.14: Canada Radiation Dose Management Market (by End User), 2019-2030 Figure 14.15: Europe Radiation Dose Management Market, 2019-2030 Figure 14.16: Europe Market Dynamics Figure 14.17: Europe Radiation Dose Management Market (by Modality), 2019-2030 Figure 14.18: Europe Radiation Dose Management Market (by End User), 2019-2030 Figure 14.19: Europe Radiation Dose Management Market (by Country), 2019-2030 Figure 14.20: Germany Radiation Dose Management Market, 2019-2030 Figure 14.21: Germany Radiation Dose Management Market (by End User), 2019-2030 Figure 14.22: France Radiation Dose Management Market, 2019-2030 Figure 14.23: France Radiation Dose Management Market (by End User), 2019-2030 Figure 14.24: Italy Radiation Dose Management Market, 2019-2030 Figure 14.25: Italy Radiation Dose Management Market (by End User), 2019-2030 Figure 14.26: U.K. Radiation Dose Management Market, 2019-2030 Figure 14.27: U.K. Radiation Dose Management Market (by End User), 2019-2030 Figure 14.28: Spain Radiation Dose Management Market, 2019-2030 Figure 14.29: Spain Radiation Dose Management Market (by End User), 2019-2030 Figure 14.30: Netherlands Radiation Dose Management Market, 2019-2030 Figure 14.31: Netherlands Radiation Dose Management Market (by End User), 2019-2030 Figure 14.32: Russia Radiation Dose Management Market, 2019-2030 Figure 14.33: Russia Radiation Dose Management Market (by End User), 2019-2030 Figure 14.34: Rest-of-Europe Radiation Dose Management Market, 2019-2030 Figure 14.35: Rest-of-Europe Radiation Dose Management Market (by End User), 2019-2030 Figure 14.36: Asia-Pacific Radiation Dose Management Market, $Million, 2019-2030 Figure 14.37: Asia-Pacific Market Dynamics Figure 14.38: Asia-Pacific Radiation Dose Management Market (by Modality), 2019-2030 Figure 14.39: Asia-Pacific Radiation Dose Management Market (by End User), 2019-2030 Figure 14.40: Asia-Pacific Radiation Dose Management Market (by Country), 2019-2030 Figure 14.41: Recommendations by the Science Council of Japan (2017) Figure 14.42: Japan Radiation Dose Management Market, 2019-2030 Figure 14.43: Japan Radiation Dose Management Market (by End User), 2019-2030 Figure 14.44: China Radiation Dose Management Market, 2019-2030 Figure 14.45: China Radiation Dose Management Market (by End User), 2019-2030 Figure 14.46: Australia and New Zealand Radiation Dose Management Market, 2019-2030 Figure 14.47: Australia and New Zealand Radiation Dose Management Market (by End User), 2019-2030 Figure 14.48: South Korea Radiation Dose Management Market, 2019-2030 Figure 14.49: South Korea Radiation Dose Management Market (by End User), 2019-2030 Figure 14.50: India Radiation Dose Management Market, 2019-2030 Figure 14.51: India Radiation Dose Management Market (by End User), 2019-2030 Figure 14.52: Rest-of-Asia-Pacific Radiation Dose Management Market, 2019-2030 Figure 14.53: Rest of Asia-Pacific Radiation Dose Management Market (by End User), 2019-2030 Figure 14.54: Latin America Radiation Dose Management Market, 2019-2030 Figure 14.55: Latin America Market Dynamics Figure 14.56: Latin America Radiation Dose Management Market (by Modality), 2019-2030 Figure 14.57: Latin America Radiation Dose Management Market (by End User), 2019-2030 Figure 14.58: Latin America Radiation Dose Management Market (by Country), 2019-2030 Figure 14.59: Brazil Radiation Dose Management Market, 2021-2030 Figure 14.60: Brazil Radiation Dose Management Market (by End User), 2019-2030 Figure 14.61: Mexico Radiation Dose Management Market, 2019-2030 Figure 14.62: Mexico Radiation Dose Management Market (by End User), 2019-2030 Figure 14.63: Rest-of-Latin America Radiation Dose Management Market, 2019-2030 Figure 14.64: Rest-of-Latin America Radiation Dose Management Market (by End User), 2019-2030 Figure 14.65: Rest-of-the-World Radiation Dose Management Market, 2019-2030 Figure 14.66: Middle East and Africa Market Dynamics Figure 14.67: Rest-of-the-World Radiation Dose Management Market (by Modality), 2019-2030 Figure 14.68: Rest-of-the-World Radiation Dose Management Market (by End User), 2021-2030 Figure 14.69: Rest-of-the-World Radiation Dose Management Market (by Country), 2019-2030 Figure 14.70: Middle East Radiation Dose Management Market, 2019-2030 Figure 14.71: Middle East Radiation Dose Management Market (by End User), 2019-2030 Figure 14.72: Africa Radiation Dose Management Market, 2019-2030 Figure 14.73: Africa Radiation Dose Management Market (by End User), 2019-2030 Figure 15.1: Agfa Gevaert Group - Product Portfolio for Radiation Dose Management Solutions Market Figure 15.2: Agfa Gevaert Group - Overall Financials, 2017-2019 Figure 15.3: Agfa-Gevaert Group- Revenue (by Segment), 2017-2019 Figure 15.4: Agfa Gevaert Group - Revenue (by Region), 2017-2019 Figure 15.5: Agfa Gevaert Group - R&D Expenditure, 2017-2019 Figure 15.6: SWOT Analysis – Agfa Gevaert Group Figure 15.7: Bayer AG- Product Portfolio for Radiation Dose Management Market Figure 15.8: Bayer AG - Overall Financials, 2017-2019 Figure 15.9: Bayer AG - Revenue (by Segment), 2017-2019 Figure 15.10: Bayer AG - Revenue (by Region), 2017-2019 Figure 15.11: Bayer AG- R&D Expenditure, 2017-2019 Figure 15.12: SWOT Analysis – Bayer AG Figure 15.13: Bracco - Product Portfolio for Radiation Dose Management Market Figure 15.14: SWOT Analysis - Bracco Figure 15.15: Canon Inc. - Product Portfolio for Radiation Dose Management Market Figure 15.16: Canon Inc. - Overall Financials, 2017-2019 Figure 15.17: Canon Inc. - Revenue (by Segment), 2017-2019 Figure 15.18: Canon Inc. - Revenue (by Region), 2017-2019 Figure 15.19: Canon Inc. - R&D Expenditure, 2017-2019 Figure 15.20: SWOT Analysis – Canon Inc. Figure 15.21: Fujifilm Holdings Corporation - Product Radiation Dose Management Market Figure 15.22: Fujifilm Holdings Corporation - Overall Financials, 2017-2019 Figure 15.23: Fujifilm Holdings Corporation - Revenue (by Segment), 2017-2019 Figure 15.24: Fujifilm Holdings Corporation - Revenue (by Region), 2017-2019 Figure 15.25: Fujifilm Holdings Corporation - R&D Expenditure, 2017-2019 Figure 15.26: SWOT Analysis - Fujifilm Holdings Corporation Figure 15.27: Guerbet Group- Product Portfolio for Radiation Dose Management Market Figure 15.28: Guerbet Group. - Overall Financials, 2017-2019 Figure 15.29: Guerbet Group - Revenue (by Segment), 2017-2019 Figure 15.30: Guerbet Group - Revenue (by Region), 2017-2019 Figure 15.31: SWOT Analysis - Guerbet LLC Figure 15.32: General Electric Company - Product Portfolio for Radiation Dose Management Market Figure 15.33: General Electric Company - Overall Financials, 2017-2019 Figure 15.34: General Electric Company - Revenue (by Segment), 2017-2019 Figure 15.35: General Electric Company (GE Healthcare) - Revenue (by Region), 2017-2019 Figure 15.36: General Electric Company - R&D Expenditure, 2017-2019 Figure 15.37: SWOT Analysis - General Electric Company Figure 15.38: Imalogix - Product Portfolio for Radiation Dose Management Market Figure 15.39: SWOT Analysis – Imalogix Figure 15.40: Infinitt Healthcare Co. Ltd- Product Portfolio for Radiation Dose Management Market Figure 15.41: SWOT Analysis – Infinitt Healthcare Co., Ltd. Figure 15.42: Koninklijke Philips N.V. - Product Portfolio for Radiation Dose Management Market Figure 15.43: Koninklijke Philips N.V. - Overall Financials, 2017-2019 Figure 15.44: Koninklijke Philips N.V. - Revenue (by Segment), 2017-2019 Figure 15.45: Koninklijke Philips N.V. - Revenue (by Region), 2017-2019 Figure 15.46: Koninklijke Philips N.V. - R&D Expenditure, 2017-2019 Figure 15.47: SWOT Analysis - Koninklijke Philips N.V. Figure 15.48: Medic Vision Imaging Solutions Ltd. - Product Portfolio Figure 15.49: SWOT Analysis – Medic Vision Imaging Solutions Ltd. Figure 15.50: Medsquare - Product Portfolio for Radiation Dose Management Market Figure 15.51: SWOT Analysis – Medsquare Figure 15.52: MyXrayDose, Ltd. - Product Portfolio Figure 15.53: SWOT Analysis – MyXrayDose, Ltd. Figure 15.54: Novarad Corporation - Product Portfolio Figure 15.55: SWOT Analysis – Novarad Corporation Figure 15.56: PACSHealth, LLC - Product Portfolio for Radiation Dose Management Market Figure 15.57: SWOT Analysis – PACSHealth, LLC Figure 15.58: Qaelum NV - Product Portfolio for Radiation Dose Management Market Figure 15.59: SWOT Analysis – Qaelum NV Figure 15.60: Sectra AB - Product Portfolio for Radiation Dose Management Figure 15.61: Sectra AB - Overall Financials, 2017/18-2019/20 Figure 15.62: Sectra AB - Revenue (by Segment), 2017/8-2019/20 Figure 15.63: Sectra AB - Revenue (by Region), 2017/18-2019/20 Figure 15.64: Sectra AB - R&D Expenditure, 2017/18-2019/20 Figure 15.65: SWOT Analysis – Sectra AB Figure 15.66: SST Group, Inc. - Product Portfolio for Radiation Dose Management Market Figure 15.67: SWOT Analysis – SST Group Inc. Figure 15.68: Siemens Healthineers, Inc. - Product Portfolio for Radiation Dose Management Market Figure 15.69: Siemens Healthineers, Inc. - Overall Financials, 2018-2020 Figure 15.70: Siemens Healthineers, Inc. - Revenue (by Segment), 2018-2020 Figure 15.71: Siemens Healthineers, Inc. - Revenue (by Region), 2018-2020 Figure 15.72: Siemens Healthineers, Inc. - R&D Expenditure, 2018-2020 Figure 15.73: SWOT Analysis - Siemens Healthineers, Inc. Figure 15.74: Virtual Phantom, Inc.- Product Portfolio for Radiation Dose Management Market Figure 15.75: SWOT Analysis – Virtual Phantoms Inc.